Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Staudt

Showing results (371-380 of 434) with videos related to

Pageof 44
Sort By:
Cancer Discovery|February 5, 2014
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphismsYibin Yang, Roland Schmitz, Joseph Mitala, et al.
Blood|September 17, 2013
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphomaAlyssa Bouska, Timothy W McKeithan, Karen E Deffenbacher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter ApproachCatalina Amador, Dennis D Weisenburger, Ana Gomez, et al.
Nature|March 4, 2011
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancersChristian Steidl, Sohrab P Shah, Bruce W Woolcock, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2008
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysGeorg Lenz, George W Wright, N C Tolga Emre, et al.
Leukemia|July 13, 2007
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphomaJ Iqbal, T C Greiner, K Patel, et al.
Science (New York, N.Y.)|October 27, 2018
The chromatin accessibility landscape of primary human cancersM Ryan Corces, Jeffrey M Granja, Shadi Shams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2019
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell LymphomaAnas Younes, Laurie H Sehn, Peter Johnson, et al.
Blood|February 15, 2007
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survivalAdrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, et al.
Science Advances|October 17, 2025
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroupWaseem G Lone, Jiayu Yu, Xuxiang Liu, et al.
Pageof 44

Showing results (371-380 of 434) with videos related to

Sort By:
Pageof 44
Cancer Discovery|February 5, 2014
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphismsYibin Yang, Roland Schmitz, Joseph Mitala, et al.
Blood|September 17, 2013
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphomaAlyssa Bouska, Timothy W McKeithan, Karen E Deffenbacher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter ApproachCatalina Amador, Dennis D Weisenburger, Ana Gomez, et al.
Nature|March 4, 2011
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancersChristian Steidl, Sohrab P Shah, Bruce W Woolcock, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2008
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysGeorg Lenz, George W Wright, N C Tolga Emre, et al.
Leukemia|July 13, 2007
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphomaJ Iqbal, T C Greiner, K Patel, et al.
Science (New York, N.Y.)|October 27, 2018
The chromatin accessibility landscape of primary human cancersM Ryan Corces, Jeffrey M Granja, Shadi Shams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2019
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell LymphomaAnas Younes, Laurie H Sehn, Peter Johnson, et al.
Blood|February 15, 2007
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survivalAdrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, et al.
Science Advances|October 17, 2025
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroupWaseem G Lone, Jiayu Yu, Xuxiang Liu, et al.
Pageof 44